| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.03 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.072 | 0.03 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.03 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.03 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.086 | 0.03 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.03 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.03 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.083 | 0.03 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.073 | 0.04 |